" class="no-js "lang="en-US"> Glaucoma Research Foundation - Medtech Alert
Thursday, October 03, 2024

Breaking News

Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Astellas and Cullgen Enter into Strategic Collaboration and Option Agreement to Advance Innovative Targeted Protein Degraders Auxilius Pharma Raises Seed Funding of $1 Million and Commences its Clinical Program Captivate Bio and EverCell Bio partner on Human Cell Modeling Services for Cell and Gene Therapy Markets Applied StemCell Partners with CIRM to Provide Clinical-Grade iPSCs and Access to Its Proprietary Gene Editing Technologies Alentis Therapeutics Receives IND Clearance from FDA for ALE.C04 for the Treatment of CLDN1+ Tumors
Glaucoma Research Foundation | Pharmtech Focus

Glaucoma Research Foundation

About Glaucoma Research Foundation

Glaucoma Research Foundation

At Glaucoma Research Foundation (GRF), our mission is to cure glaucoma and restore vision through innovative research. For 40 years, GRF has worked to advance sight-saving research and provide essential educational resources for patients. We fund critical research into glaucoma treatment, vision restoration, and a cure. Our bold vision is a future free from glaucoma.

Related Story

Diseases

 Glaucoma Research Foundation Launches Catalyst for a Cure Initiative to Prevent and Cure Neurodegeneration | Pharmtech Focus

Glaucoma Research Foundation Launches Catalyst for a Cure Initiative to Prevent and Cure Neurodegeneration

July 19 2022

Glaucoma Research Foundation (GRF), a national non-profit organization dedicated to finding a cure for glaucoma, has […]